Physician profile
Xiaoyan Guo
NPI 1548290661
$22,342.50
in general payments reported to CMS, 2019-2025
75 companies · $3,074 in 2025
The $3,074 reported for 2025 was more than what 79% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,231 · 2020: $2,081 · 2021: $4,296 · 2022: $3,148 · 2023: $3,655 · 2024: $3,858 · 2025: $3,074.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,362.36 |
| Education | $225.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,775.79 | 2019-2025 | Briviact, Rystiggo, Nayzilam |
| Abbvie INC. | $1,335.45 | 2021-2025 | |
| Upsher-Smith Laboratories LLC | $980.14 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $944.83 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Sk Life Science, INC. | $913.60 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $751.70 | 2019-2025 | |
| Neurelis, INC. | $721.50 | 2021-2025 | Valtoco |
| Alexion Pharmaceuticals, INC. | $685.37 | 2019-2025 | Ultomiris, Soliris |
| Lilly USA, LLC | $666.58 | 2019-2025 | Amyvid, Emgality, Kisunla |
| Scilex Pharmaceuticals INC. | $627.81 | 2022-2025 | Ztlido |
| Lundbeck LLC | $598.34 | 2019-2025 | Vyepti, Rexulti |
| Eisai INC. | $583.90 | 2019-2025 | |
| Mdd US Operations, LLC | $530.77 | 2019-2025 | Gocovri, Gocovri, Qelbree |
| Biohaven Pharmaceuticals, INC. | $528.73 | 2020-2021 | |
| Pfizer INC. | $513.99 | 2021-2025 |
Show all 75 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaoyan Guo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.